- Home
- LECO vs GMAB Comparison
LECO vs GMAB Comparison
Compare LECO & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LECO
- GMAB
- Stock Information
- Founded
- LECO 1895
- GMAB 1999
- Country
- LECO United States
- GMAB Denmark
- Employees
- LECO N/A
- GMAB N/A
- Industry
- LECO Industrial Machinery/Components
- GMAB Biotechnology: Pharmaceutical Preparations
- Sector
- LECO Industrials
- GMAB Health Care
- Exchange
- LECO Nasdaq
- GMAB Nasdaq
- Market Cap
- LECO 13.4B
- GMAB 13.2B
- IPO Year
- LECO N/A
- GMAB N/A
- Fundamental
- Price
- LECO $245.25
- GMAB $24.65
- Analyst Decision
- LECO Buy
- GMAB Buy
- Analyst Count
- LECO 8
- GMAB 6
- Target Price
- LECO $234.63
- GMAB $37.60
- AVG Volume (30 Days)
- LECO 351.3K
- GMAB 1.2M
- Earning Date
- LECO 07-31-2025
- GMAB 08-07-2025
- Dividend Yield
- LECO 1.26%
- GMAB N/A
- EPS Growth
- LECO 0.60
- GMAB 77.72
- EPS
- LECO 8.90
- GMAB 21.62
- Revenue
- LECO $4,098,850,999.00
- GMAB $3,646,881,232.00
- Revenue This Year
- LECO $4.07
- GMAB $21.64
- Revenue Next Year
- LECO $4.43
- GMAB $15.57
- P/E Ratio
- LECO $27.56
- GMAB $11.06
- Revenue Growth
- LECO 0.10
- GMAB 32.97
- 52 Week Low
- LECO $161.11
- GMAB $17.24
- 52 Week High
- LECO $246.83
- GMAB $27.94
- Technical
- Relative Strength Index (RSI)
- LECO 63.45
- GMAB 67.82
- Support Level
- LECO $236.52
- GMAB $21.00
- Resistance Level
- LECO $241.72
- GMAB $22.90
- Average True Range (ATR)
- LECO 4.64
- GMAB 0.43
- MACD
- LECO -0.91
- GMAB 0.24
- Stochastic Oscillator
- LECO 88.20
- GMAB 95.31
About LECO Lincoln Electric Holdings Inc.
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, and brazing and soldering alloys, as well as automation solutions. Lincoln Electric serves clients in the general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among other end markets. Based in Cleveland, Lincoln Electric has operations in 19 countries and has 11,000 employees worldwide. The company generated roughly $4 billion in sales in 2024.
About GMAB Genmab A/S ADS
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.